This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: John F Englehardt: Innovator in Gene Therapy
Introduction
John F Englehardt is a prominent inventor based in Iowa City, IA (US). He has made significant contributions to the field of gene therapy, particularly through his work on adeno-associated virus (AAV) vectors. His innovative approach has the potential to advance therapeutic techniques in various medical applications.
Latest Patents
Englehardt holds a patent for "Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences." This invention provides recombinant AAV vectors, at least one of which has heterologous terminal palindromic sequences, along with methods for utilizing those vectors. His work in this area is crucial for developing effective gene delivery systems.
Career Highlights
Englehardt is affiliated with the University of Iowa Research Foundation, where he continues to push the boundaries of research in gene therapy. His dedication to innovation has led to advancements that could significantly impact the treatment of genetic disorders.
Collaborations
Englehardt collaborates with Ziying Yan, contributing to the advancement of their shared research interests. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
John F Englehardt's contributions to gene therapy through his patented inventions highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical science and therapeutic applications.